Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study

Wenpei Shi,Yi Hu,Zhu Ning,Fan Xia,Meiying Wu,Yue O O Hu,Cheng Chen,Stefanie Prast-Nielsen,Biao Xu,Yue O.O. Hu
DOI: https://doi.org/10.1016/j.ijid.2021.08.064
IF: 12.073
2021-10-01
International Journal of Infectious Diseases
Abstract:BackgroundThis study aimed to identify the differences in diversity, composition and function of gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).MethodsA cross-sectional study was conducted in three cities of China. Stools samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their uses of non-specific antibiotics before TB diagnosis.ResultsCompared with HCs, antibiotic-free TB patients presented a different gut microbial community (P<0.005) and decreased shannon diversity (P<0.005). Among TB patients, the relative abundances of short-chain-fatty-acids(SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC)=-2.74) were lower, while several conditional pathogens related genera such as Enterococcus (log2(FC)=12.05) and Rothia (log2(FC)=6.322) were at higher levels. In addition, 41% patients received antibiotics before TB diagnosis. The antibiotics exposure was correlated with additional reduction of α-diversity and depletion of SCFA-producing-bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.ConclusionsSignificant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotics exposure could alter gut microbiota of TB patients which should be considered in anti-TB treatment.
infectious diseases
What problem does this paper attempt to address?